/Huntington%20Bancshares%2C%20Inc_%20bank%20branch-by%20jetcityimage%20via%20iStock.jpg)
Columbus, Ohio-based Huntington Bancshares Incorporated (HBAN) operates as the bank holding company for The Huntington National Bank that provides commercial, consumer, and mortgage banking services. The company has a market cap of $32 billion and offers financial products and services to consumer and business customers, including deposits, lending, payments, mortgage banking, dealer financing, investment management, and more.
Companies with a market cap of $10 billion or more are typically referred to as “large-cap stocks.” HBAN fits squarely in that category, with a market cap above this threshold that reflects its size and influence in the regional banks industry.
Despite its strength, HBAN stock slipped 19.7% from its 52-week high of $19.45, reached on Feb. 6. The stock is down 7.3% over the past three months, lagging behind the S&P 500 Index’s ($SPX) 2.6% rise during the same time frame.
Moreover, the scenario remains the same in the longer term. The stock has fallen 11% over the past 52 weeks, while SPX delivered 15.4% returns over the same time frame, outperforming the stock.
HBAN has been trading below its 200-day moving average since this month, and also below its 50-day moving average since August.
On July 23, HBAN stock declined 4.8% following the release of its mixed Q2 2026 earnings. The company’s revenue for the quarter amounted to $4.2 billion, coming in above Wall Street’s estimates. Additionally, its adjusted EPS came in at $0.39, matching the Street’s estimates. More recently, the company cut its 2027 EPS estimate to $1.75 to $1.83 from an April outlook of $1.90 to $1.93, also resulting in a 6% decline in its price.
When stacked against its rival, M&T Bank Corporation (MTB), HBAN has underperformed. Over the past year, MTB stock has grown 13.7%.
Analysts’ view of HBAN stock is somewhat bullish. Among the 21 analysts covering the stock, the overall consensus rating is “Moderate Buy.” Its mean price target of $20.04 offers a 27.4% upside potential.
